102 体外诊断试剂盒用什么改性尼龙
试剂盒外壳的分件
体外诊断试剂盒外壳分试杯 + 反应管 + 管盖 + 外壳四件，料各不相同。试杯接触样本——必须生物相容 + 抗化学。
反应管是核心——必须有透明窗口 + 抗蛋白吸附。管盖是密封件——必须弹性好 + 密封稳定。外壳是结构件——可以 PP + 玻纤增强。
PA 在这里不用——透明度、阻隔性、生物相容均不达标。
现场还原
去年夏天，一家体外诊断试剂厂的自动化产线上，工程师给我们看了一段慢放的录像，试剂盒在传送带上进分析仪的瞬间，有一小部分被导轨卡住，机器停机报警。卡住的那几盒是同一批注塑的，侧壁的翘曲比正常批大了零点二毫米。
零点二毫米在人工上机的年代无感，在自动上机的年代就是停机。他们把那批料和正常批的对比，收缩率差了一丝。自动化时代对塑料件的公差要求被整机厂重新定义了，人和机器对误差的宽容度，隔着一条产线的效率。
试杯的材料
试杯接触血液、尿液等样本——主流走 PP——化学稳定、生物相容、单价低。PP 必须 USP Class VI 认证——这是诊断试剂的硬门槛。
PE 也是选项——更柔软，但透明度不如 PP。试杯的关键是抗蛋白吸附——PP 经过表面处理（等离子处理）后抗吸附最优。
反应管的材料
反应管是试剂盒的核心——必须有透明窗口 + 抗蛋白吸附。主流走 PS（聚苯乙烯）——透明度最优，单价低。
高端走 COC / COP（环烯烃聚合物）——透明度优于 PS 5 倍，单价是 PS 的 5 倍——荧光定量 PCR 等高端检测必须 COC / COP。任何蛋白吸附都会干扰检测结果——必须做表面处理。
管盖的细节
管盖是密封件 + 弹性件——主流走 PP + TPE——PP 提供刚性，TPE 提供密封。管盖的密封必须验证——气密性 + 水密性 + 长期密封稳定。
任何泄漏都会污染样本——这是诊断试剂的最大风险。管盖的颜色必须稳定——不同颜色对应不同样本，褪色是严重质量问题。
外壳的结构设计
外壳是结构件 + 外观件——主流走 PP + 玻纤——PP-GF20 是主流。外壳要抗冲击——跌落 1.5 m 不破——诊断试剂运输过程中的硬要求。
外壳要阻燃——部分诊断设备（PCR 仪、化学发光仪）外壳必须 UL94 V-0。外壳的颜色和印刷——标签必须耐酒精擦拭 1000 次不掉色。
延伸判断：试剂盒的隐性变量
试剂盒有三件容易漏掉的隐性变量。一是样本互混——多通道试剂盒的样本可能互混，反应管必须独立密封——任何通道泄漏都会导致整个试剂盒失效。
二是温度耐受——试剂盒要耐 4℃ 冷藏和 37℃ 孵育——所有塑料件必须通过冷热循环测试。三是光学性能——荧光检测的试剂盒必须透明度极高，COC 是高端方案——普通 PS 不够。
深一层：几个数字的来历
试剂盒外壳的分件逻辑是底座加盖加卡扣，底座管定位和堆叠，盖管防尘和开启手感，卡扣管封合。三个件的公差要求不同，底座的平面度直接决定上机定位，平面度超差的批在自动上机的故障率飙升，底座的模具和料的收缩控制是产线效率的隐藏变量。
试杯和反应管是试剂盒里的精密件，杯壁的光洁度影响光学检测的本底，微量的荧光干扰都能污染结果。
透明料的纯度和脱模剂的使用量要严格控制，脱模剂多了，杯壁的残留干扰检测，脱模剂少了顶出拉伤，这个平衡要靠模具的抛光和顶出的平衡找，料的牌号定了之后不要轻易换。
管盖的密封是一次性的密封设计，开盖的手感和密封的可靠性是一对矛盾，密封太好护士开不动，太松运输漏液。旋盖扭矩的窗口按女性操作者的手感定，这个窗口比多数厂定的要窄，窗口外的批在临床上两种结局，开不开和漏不漏，都是投诉。
外壳的结构设计里最容易被低估的是堆叠强度，试剂的冷链运输里纸箱堆叠七八层，底层的试剂盒承受的压力不轻，薄壁化的外壳在堆叠里蠕变变形，堆叠之后开盖困难或者上机卡壳。
堆叠测试要按运输的实际层数做，温度还要按冷链的下限做，低温下材料变硬变脆，堆叠的失效模式会变。
低温是试剂盒的常态工况，冷链存储两到八度，取出上机之后又有冷凝水，反复的低温和回温让尺寸漂移。密封件的低温弹性变化直接影响密封，垫片料的低温压缩永久变形要专门验证，常温密封合格的批，低温下可能就是漏的，冷链产品的验证不能离开冷链。
批间一致性是诊断行业的生命线，试剂盒的塑料件换了批，光学性能和几何公差的漂移都会传导到检测结果上。
料厂的批间稳定性报告在这里比价格重要，把进料的控制图建起来，批间的波动看得见，检测结果的可比性才有底，诊断试剂的口碑建立在每一次结果的可重复上。
工程实测：四条强制测试
测试1：生物相容 USP Class VI。PP / PS 全套通过，COC / COP 通过更全——必须 USP Class VI 认证。
测试2：透明度。COC 透光率 92%，PS 80%，PP 65%——荧光定量 PCR 必须 COC。
测试3：抗蛋白吸附。COC + 等离子处理抗吸附率 95%，纯 PS 70%——必须表面处理。
测试4：冷热循环 100 次。PP / PS / COC 在 4℃ ↔ 37℃ 循环 100 次无变形——必须冷热循环验证。
边界声明
| 工况 | 推荐材料 |
|---|
| 试杯 | PP（USP Class VI） |
| 反应管 | PS / COC / COP |
| 管盖 | PP + TPE |
| 外壳 | PP-GF20 + 阻燃 |
| 高端 PCR | 必须 COC / COP |
工程备忘
体外诊断试剂盒四件分料，PP / PS 是基础——荧光定量 PCR 必须 COC / COP。样本互混、温度耐受、光学性能三个隐性变量——诊断试剂质量的隐性细节。
追问三连
问一：试剂盒外壳用透明料还是不透明？光路敏感的检测项目用不透明料挡杂光，需要目视观察液面的用透明。同一款试剂盒的不同件可以两种料并用，按件的光学角色定，不是整盒统一。
问二：微流控芯片的基材为什么不用尼龙？微流控的表面性质是通道设计的核心，PDMS 和环烯烃类 dominate 这块，尼龙的吸水和表面化学都不占优。尼龙在诊断行业的位置在结构件和卡匣外壳，认清位置比硬闯重要。
问三：上机兼容性怎么确认？和仪器厂的接口文件要对齐，尺寸公差、导轨配合面、识别标签的位置都有约定。和整机厂共建公差文件是上机兼容的根本，材料收缩的稳定性是公差文件能成立的前提。
反向案例与收尾判断
某试剂厂的试剂盒换了一批便宜的盖料，密封测试合格，三个月后西南地区的客户投诉漏液，那批试剂在冷链运输里经历了高原的低气压，密封在低压下失效。平原验证过的密封方案在高原运输里不成立，这个批次的损失让厂家把运输环境的气压纳入验证项。
诊断试剂的工况清单里有太多隐藏变量，温度、气压、湿度、堆叠，每一个都可能成为下一个漏液的来源，验证矩阵的宽度就是这个行业的风险敞口。
实战案例：常见踩坑与正解
踩坑一：按家用件物性表直接套到医疗场景，结果体外诊断试剂盒半年内出现溶出 / 灭菌降解 / 生物相容不合格。
正解：医疗是合规门槛最高的场景——任何医用件必须 ISO 10993 + USP Class VI 全套验证，家用件物性表完全不适用——这是 90% 医疗件注册失败的根因。
踩坑二：用同一种料做整件，结果密封圈和外壳的溶出不同——整件注册失败。正解：密封件、外壳、连接件分别选料，每件单独做溶出验证，不同料的溶出物不能混算。
踩坑三：灭菌方式选择错误——EO 残留超标或 γ 射线降解。正解：灭菌方式与料号匹配——EO 走 PE / PP，γ 射线走 PSU / PA，必须提前验证。
少一项注册就失败，补救成本是新设计的 3 倍。这三个坑都是量产前必须自查的清单。
补记：四条来自诊断行业的延伸判断
诊断行业把塑料件当耗材卖的模式正在扩展，试剂盒加耗材加备件的整体方案，塑料件从成本项变成收入项。
试杯、吸头、卡匣这些高频耗材的标准化程度高，量起得快，材料的一致性是耗材生意的根基，料厂和试剂厂的绑定关系在这种模式下越走越深，长协加专用牌号是常见的形态。
分子诊断的爆发带来高精度的塑料件需求，微孔板的孔间一致性、热盖的温度均匀性，都直接落在材料的导热和尺寸稳定上。这波需求的单价和门槛都高，国产替代的空间大，有精密注塑能力的厂和有特种料的厂在这个细分里是天然的搭档，早建合作早占位。
POCT 的家用化把诊断产品推进消费场景，家用检测的外观要求、操作手感、误操作的防呆设计，全是消费电子的思路。家用检测的塑料件验证要加儿童接触的评估，这是诊断行业向消费行业学的新课，两个行业的合规逻辑在这一代产品里交汇。
诊断设备的国产化带动配套塑料件的国产化，整机厂对国内料厂的接受度在提高，验证窗口是留给准备好的厂的。
把诊断行业常用的验证清单整理成标准包，客户验证周期从几个月压到几周，响应速度在 B 端的转化率上立竿见影，服务的产品化是材料厂在诊断行业最有效的敲门砖。
增补：另四条来自一线的观察
观察之一，试剂盒的环保趋势在包装端先落地，纸质内托替代塑料内托，缓冲材料和盒体的配合要重新验证。环保材料的性能波动比传统材料大，验证的样本量要放大，绿色转型的成本里有相当一部分是验证成本，提前把验证方法建好的厂，转型的时候最从容。
观察之二，冷链物流的可视化给塑料件带来新的验证视角，运输全程的温度记录可以让失效归因到具体环节。有家厂靠温度记录把一批漏液的责任归到物流环节的异常高温，材料商免了冤枉的赔偿，温度数据的留存是纠纷时的证据链，建议出货标配。
观察之三，诊断行业的供应商审核频率在提高，年度审核加飞行检查，材料供应商被审核成了常态。
把审核材料做成常备包，体系文件、验证报告、变更记录一次备齐，审核通过率就是订单的稳定器，被审核的次数多了就会发现，准备好的供应商和临时应付的供应商，拿到的订单份额差一倍。
观察之四，诊断设备厂和试剂厂的封闭系统之争，让塑料件的接口标准成了博弈点，封闭系统的耗材件利润高但绑定深，开放系统的量大利润薄。
塑料件厂在两条路线里的位置选择影响未来五年的生意结构，跟封闭系统吃技术溢价，跟开放系统吃规模效应，两头下注是最稳的姿态。
结语
料有人卖，判断不一定有人给——医疗件选料的每一个判断，都是临床安全。
医疗器械整套医用件的选料与试模，可以一起聊。
What type of modified nylon is used for 102 in vitro diagnostic kits
Component parts of the reagent kit casing
IVD kit outer shell consists of four parts: reaction cup, reaction tube, tube cap, and outer shell, each made of different materials. The cup comes into contact with the sample — it must be biocompatible and chemically resistant.
The reaction tube is the core—it must have a transparent window and be resistant to protein adsorption. The tube cap is the seal—it must be elastic and provide stable sealing. The outer shell is the structural component—it can be made of PP with glass fiber reinforcement.
PA is not used here——it does not meet the standards for transparency, barrier properties, or biocompatibility.
On-site restoration
Last summer, on the automated production line of an in vitro diagnostic reagent factory, an engineer showed us a slow-motion video. At the moment the reagent kits entered the analyzer on the conveyor belt, a small portion got stuck on the guide rail, triggering the machine to stop and alarm. The kits that got stuck were from the same batch of injection molding, and the warping of their sidewalls was 0.2 millimeters larger than that of a normal batch.
0.2 millimeters was negligible in the era of manual machining, but in the era of automated machining, it meant a halt. They compared that batch of material with a normal batch and found a slight difference in shrinkage rate. In the era of automation, the tolerance requirements for plastic parts were redefined by the complete machine manufacturers, and the tolerance for errors between humans and machines affected the efficiency of an entire production line.
Materials for the tasting cup
Test cups come into contact with blood, urine, and other samples — mainstreamly made of PP — chemically stable, biocompatible, and low-cost. PP must have USP Class VI certification — this is a strict requirement for diagnostic reagents.
PE is also an option—softer, but not as transparent as PP. The key for trial cups is protein adsorption resistance—PP has the best anti-adsorption after surface treatment (plasma treatment).
Reaction tube material
The reaction tube is the core of the kit - it must have a transparent window and be resistant to protein adsorption. The mainstream choice is PS (polystyrene) - optimal transparency and low unit price.
High-end uses COC / COP (cyclic olefin copolymer) — transparency is 5 times better than PS, unit price is 5 times that of PS — high-end tests such as fluorescent quantitative PCR must use COC / COP. Any protein adsorption will interfere with test results — surface treatment is necessary.
Details of the cap
The tube cap is a sealing component. Elastic components—mainstream use PP. TPE—PP provides rigidity, TPE provides sealing. The sealing of the tube cap must be verified—airtightness, watertightness, and long-term sealing stability.
Any leakage will contaminate the sample — this is the greatest risk of diagnostic reagents. The color of the tube cap must remain stable — different colors correspond to different samples, and fading is a serious quality issue.
The structural design of the shell
The casing is a structural part. For appearance parts, the mainstream material is PP. For glass fiber, PP-GF20 is the mainstream. The casing must be impact-resistant—should not break when dropped from 1.5 m—which is a strict requirement during the transportation of diagnostic reagents.
The casing must be flame-retardant—some diagnostic equipment (PCR machines, chemiluminescence analyzers) must have a UL94 V-0 rated casing. The color and printing of the casing—the labels must withstand 1,000 alcohol wipes without fading.
Extended Judgment: The Hidden Variables of the Test Kit
There are three hidden variables in the reagent kit that are easy to overlook. First is sample cross-contamination—samples in a multichannel reagent kit may mix, so reaction tubes must be sealed independently—any channel leakage can cause the entire reagent kit to fail.
Second is temperature tolerance—the kit must withstand 4℃ refrigeration and 37℃ incubation—all plastic parts must pass thermal cycling tests. Third is optical performance—kits for fluorescence detection must have very high transparency; COC is a high-end solution—ordinary PS is not enough.
A deeper look: The origin of a few numbers
The assembly logic of the reagent kit casing consists of a base, a lid, and a buckle. The base is for tube positioning and stacking, the lid is for dust protection and opening feel, and the buckle is for sealing. The three parts have different tolerance requirements. The flatness of the base directly determines machine placement accuracy; batches with flatness beyond tolerance cause a surge in automatic machine failure rates. Controlling mold and material shrinkage for the base is a hidden variable for production line efficiency.
Test cups and reaction tubes are precision parts in the kit; the smoothness of the cup wall affects the background of optical detection, and even trace amounts of fluorescent interference can contaminate the results.
The purity of the transparent material and the amount of release agent must be strictly controlled. If there is too much release agent, the residue on the cup wall interferes with testing; if there is too little, ejection can cause scratches. This balance must be achieved through mold polishing and balanced ejection. Once the material grade is determined, it should not be changed easily.
The sealing of the cap is a one-time use sealing design. There is a contradiction between the feel of opening the cap and the reliability of the seal: if the seal is too tight, nurses cannot open it; if it is too loose, it may leak during transport. The torque window for screwing the cap is set according to the feel for female operators. This window is narrower than that set by most manufacturers. Outside of this window, in clinical practice, there are two possible outcomes: either the cap cannot be opened or it leaks, and both lead to complaints.
The aspect most easily underestimated in the structural design of the casing is stacking strength. In the cold chain transportation of reagents, cardboard boxes are stacked seven to eight layers high, and the reagent kits at the bottom endure considerable pressure. Thin-walled casings can creep and deform under stacking, making it difficult to open the lid after stacking or causing jams when placed in machines.
Stacking tests should be conducted according to the actual number of layers for transportation, and the temperature should follow the lower limit of the cold chain. At low temperatures, materials become harder and more brittle, and the failure modes of stacking will change.
Low temperature is the normal operating condition for reagent kits. They are stored in the cold chain at two to eight degrees Celsius, and after being taken out for use, condensation forms. Repeated low temperature and warming cycles cause dimensional drift. The low-temperature elasticity changes of seals directly affect sealing, and the low-temperature permanent deformation of gasket materials must be specifically verified. Batches that pass sealing tests at room temperature may leak at low temperatures, so verification of cold chain products cannot be separated from the cold chain.
Inter-batch consistency is the lifeline of the diagnostic industry. When the plastic components of a kit are changed to a different batch, shifts in optical performance and geometric tolerances can be transmitted to the test results.
The inter-batch stability report of the material plant is more important here than the price. Establish control charts for the incoming materials so that inter-batch fluctuations are visible. Only then can the comparability of test results be reliable, and the reputation of diagnostic reagents is built on the repeatability of each result.
Engineering Test: Four Mandatory Tests
Test 1: Biocompatibility USP Class VI. Complete PP/PS passes, COC/COP passes more comprehensively — USP Class VI certification is required.
Test 2: Transparency. COC light transmittance 92%, PS 80%, PP 65%——Fluorescent quantitative PCR must use COC.
Test 3: Anti-protein adsorption. COC plasma treatment anti-adsorption rate 95%, pure PS 70%—surface treatment is required.
Test 4: 100 cycles of cold and hot. PP / PS / COC show no deformation after 100 cycles between 4℃ ↔ 37℃ — cold and hot cycle verification is required.
Boundary Declaration
| Operating condition | Recommended materials |
|---|
| Tasting glass | PP (USP Class VI) |
| Reaction tube | PS / COC / COP |
| Cap | PP TPE |
| Shell | PP-GF20 Flame Retardant |
| High-end PCR | COC / COP required |
Engineering Memo
Four in vitro diagnostic kits are divided into four parts, PP/PS is the foundation—fluorescent quantitative PCR must be COC/COP. Sample mixing, temperature tolerance, and optical performance are three hidden variables—the implicit details of diagnostic reagent quality.
Follow-up question:
Question 1: Should the kit casing be transparent or opaque? For detection projects sensitive to light paths, opaque materials are used to block stray light; for those requiring visual observation of the liquid surface, transparent materials are used. Different parts of the same kit can be used together, depending on the optical function of each piece, not the whole box.
Question 2: Why doesn't nylon be used as the substrate for microfluidic chips? The surface properties of microfluidics are the core of channel design. For PDMS and cycloolefin dominates, nylon is not dominant in terms of water absorption and surface chemistry. Nylon's position in the diagnostic industry lies in structural components and cartridge housings; knowing the exact position is more important than forcing a hard breakthrough.
Question 3: How to confirm compatibility with the machine? Interface files with instrument manufacturers must be aligned, with agreement on dimensional tolerances, guide rail mating surfaces, and identification label positions. Jointly establishing tolerance files with the manufacturer is fundamental to machine compatibility, and the stability of material shrinkage is the prerequisite for tolerance documents to be valid.
Reverse Case and Final Judgment
A reagent factory's reagent kit was replaced with cheap cap material, and the sealing test passed. Three months later, a customer in Southwest China complained about leakage. That batch of reagents experienced low plateau pressure during cold chain transport, and the seal failed under low pressure. The sealing solution verified by Pingyuan did not work in plateau transportation, and the loss of this batch led the manufacturer to include air pressure in the transportation environment as a validation item.
The diagnostic reagent working condition list contains too many hidden variables: temperature, pressure, humidity, stacking. Each could become the next source of leakage. The width of the validation matrix is the industry's risk exposure.
Practical Case: Common pitfalls and correct answers
Pitfall 1: Applying the physical property table of household items directly to medical scenarios, resulting in vitro diagnostic kits showing dissolution/sterilization degradation/biocompatibility failure within six months.
Correct answer: Medical devices have the highest compliance threshold—any medical device must undergo full ISO 10993 + USP Class VI verification, and the physical property table for household items is completely inapplicable—this is the root cause of 90% of medical device registration failures.
Pitfall 2: Using the same material for a whole piece, the sealing ring and shell result in different leaching results—whole device registration fails. Correct answer: Materials for sealing, housing, and connector are selected separately, and each is tested separately for dissolution; leached products from different materials cannot be combined.
Pitfall 3: Incorrect sterilization method choice—EO residue exceeds limits or γ radiation degradation. Correct answer: Sterilization method matches part number—EO goes PE/PP, γ goes PSU/PA, must be verified in advance.
Missing one registration means failure; remedial costs are three times higher than new designs. These three pitfalls are checklists that must be checked before mass production.
Supplement: Four extended judgments from the diagnostic industry
The diagnostic industry's model of selling plastic parts as consumables is expanding, with the overall plan of reagent kits, consumables, and spare parts, transforming plastic parts from cost items into revenue items.
high-frequency consumables like test cups, tips, and cartridges are highly standardized and can be massed quickly. Material consistency is the foundation of the consumables business. The binding between material factories and reagent factories deepens in this model, with long-term contracts plus dedicated grades being common. The explosion of
molecular diagnostics has brought demand for high-precision plastic parts. The consistency between micro-plates and the temperature uniformity of thermal caps directly depend on material thermal conductivity and dimensional stability. This wave of demand has high unit prices and thresholds, with large room for domestic substitution. Factories with precision injection molding capabilities and specialty materials are natural partners in this segment—early cooperation means securing positions.
POCT's home-use approach pushes diagnostic products into consumer scenarios. The appearance requirements, handling feel of home testing, and foolproof design for misoperation are all consumer electronics concepts. Verification of plastic parts for home testing must include child contact assessments. This is a new lesson the diagnostics industry has learned from the consumer industry, and the compliance logic of the two industries converge in this generation of products.
Localization of diagnostic equipment drives the localization of supporting plastic parts, increasing acceptance of domestic material manufacturers by OEMs, and the validation window is reserved for those who are ready.
compiles commonly used verification checklists in the diagnostic industry into standard packages, reducing customer validation cycles from months to weeks, with immediate response speed and B-end conversion rates. Productization of services is the most effective gateway for material manufacturers in the diagnostic industry.
Supplement: Another four observations from the front line
One of their observations is that the eco-friendly trend of test kits is first implemented on the packaging side, paper inner trays replace plastic ones, and the coordination between cushioning materials and the box body must be re-verified. Environmental materials have greater performance fluctuations than traditional materials, requiring larger sample sizes for validation. A significant portion of the cost of green transformation is validation. Factories that build validation methods in advance are the most confident during transformation.
Observation Two: Visualization of cold chain logistics brings new verification perspectives to plastic parts. Temperature records throughout transportation can attribute failures to specific stages. One factory used temperature records to blame for leaks on abnormal high temperatures in logistics, exempting material suppliers from unjust compensation. Retention of temperature data serves as a chain of evidence in disputes, and shipments are recommended.
Observation Three: Supplier audits in the diagnostics industry are increasing frequency, with annual audits plus spot checks, making it routine for material suppliers to be audited.
Turn audit materials into a regular package, preparing system files, verification reports, and change records all at once. The approval rate acts as the order stabilizer. After being audited multiple times, you'll find that the order share is twice as big as the one who is prepared and the one who only handles it.
Observation Four: The closed system competition between diagnostic equipment manufacturers and reagent factories has turned the interface standards for plastic parts into a bargaining point. Closed systems have high consumables but are deeply bound, while open systems have large volumes but thin profits.
Plastic parts factories choose between two routes that will influence their business structure over the next five years: they compete with closed systems for technology premiums, while open systems rely on economies of scale. Betting on both sides is the most stable approach.
Conclusion
Some sell materials, but judgment doesn't always have to be given — every judgment in selecting medical device materials is clinical safety.
For the selection and mold trials of complete sets of medical device parts, you can chat together
